Nepal vs Togo: Cause of death, by non-communicable diseases, ages 60+, female
Nepal
71.1%
in 2021
Togo
71.5%
in 2021
Nepal rank
111th
Togo rank
109th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Nepal
- Togo
How they compare
Togo currently reports 71.5% against 71.1% in Nepal, a difference of 0.4%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Togo ahead.
Nepal ranks 111th and Togo ranks 109th of 185 countries.
Across the 3 decades both report, Nepal averaged higher in 2 and Togo in 1.
Head to head by decade
| Decade | Nepal | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 68.1% | 69.3% | 1.2% | Togo |
| 2010s | 78.3% | 73.3% | 5.1% | Nepal |
| 2020s | 74.1% | 72.8% | 1.3% | Nepal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Nepal or Togo?
- Togo, at 71.5% against 71.1% in Nepal as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Nepal and Togo?
- 0.4%, with Togo ahead.
- How many years of comparable data are there for Nepal and Togo?
- 6 years are reported by both, from 2000 to 2021.
- How do Nepal and Togo rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Nepal ranks 111th and Togo ranks 109th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.